Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Thomas Winkler has worked on the following 17 EPO patent applications which have been published in the last five years:

EP12735395

ANTI-C-MET ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12748808

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12768982

COMBINATION TREATMENTS COMPRISING C-MET ANTAGONISTS AND B-RAF ANTAGONISTS

IPC classification:
A61K 31/437, A61K 31/4439, A61K 39/395, A61K 45/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12778020

ZYMOGEN ACTIVATORS

IPC classification:
A61K 38/18, C07K 7/06, C07K 14/475
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12794841

PURIFICATION OF ANTI-C-MET ANTIBODIES

IPC classification:
C07K 16/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13791411

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13736741

EXPRESSION AND SECRETION SYSTEM

IPC classification:
C12N 15/64, C12N 15/74, C12N 15/76
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14757519

METHODS OF MODULATING DLK STABILITY

IPC classification:
A61K 31/7105, A61K 39/395, A61P 25/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14756179

COMPOSITIONS AND METHOD FOR TREATING COMPLEMENT-ASSOCIATED CONDITIONS

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14827379

ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 14/71, C07K 16/18, C07K 16/28, C07K 16/46
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15716253

CANCER TREATMENT WITH C-MET ANTAGONISTS AND CORRELATION OF THE LATTER WITH HGF EXPRESSION

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721516

ANTI-FACTOR D ANTIBODY VARIANTS AND USES THEREOF

IPC classification:
C07K 16/40, C12N 9/64
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16193134

PREDICTING PROGRESSION TO ADVANCED AGE-RELATED MACULAR DEGENERATION USING A POLYGENIC SCORE

IPC classification:
C12Q 1/68, G06F 19/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
APPLICATION PUBLISHED
EP15742329

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IPC classification:
C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16193195

LOW AFFINITY ANTI TRANSFERRIN RECEPTOR AND THEIR USE TO TRANSFER THERAPEUTIC SCFV ACROSS THE BLOOD BRAIN BARRIER

IPC classification:
A61K 39/395, C07K 16/18, C07K 16/28, C07K 16/40, C07K 16/46
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
The application has been published
EP17160544

FGFR1 AGONISTS AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 3/10, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
The application has been published
EP17174320

TYPE II ANTI-CD20 ANTIBODY AND ANTI-CD20/CD3 BISPECIFIC ANTIBODY FOR TREATMENT OF CANCER

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Winkler, F. Hoffmann-La Roche AG
Status:
The application has been published

Please Sign in to use this feature